However, a small study in a heterogeneous population of cancer patients showed that PET PD-L1 signal was significantly correlated with response to checkpoint inhibitor but not immunohistochemistry due to significant tumor heterogeneity found on imaging [67]. Here, CD274 is linked to cancer.